全球人工水晶體（IOL）市場 - 市場規模（依細分市場）、佔有率、監管、償付、治療、預測（~2033年）

視力障礙嚴重影響成年人的生活品質。有視力障礙的成年人的勞動參與度和生產力往往較低。對於老年人來說，視力喪失可能導致社會孤立、行走困難、跌倒和骨折的風險增加，以及提前入住療養院或輔助生活設施的可能性增加。隨著人口的成長和老化，預計會有更多的人出現視力障礙的風險增加。視力恢復和復健對於改善因白內障、糖尿病視網膜病變、青光眼、外傷後遺症、老年黃斑部病變等眼部疾病引起的不可逆視力喪失的人的功能非常有效。

本報告研究和分析了全球人工水晶體（IOL）市場，提供了有關主要參與者和市場佔有率、主要趨勢、創新產品和技術以及競爭格局的資訊。

市場模型的主要內容如下。

已上市的人工水晶體（IOL）和不斷變化的競爭格局

• 對主要產業趨勢的考察
• 人工水晶體（IOL）市場年收入和市場前景（依細分市場）（2015-2033年）
• 依細分市場劃分的手術總數、單位數量、平均售價和市場價值的詳細資料

全球、區域和國家層面的特定市場考察

• 依地區細分全球趨勢的特定市場定性資訊和國家考察
• 人工水晶體（IOL）市場的 SWOT 分析
• 人工水晶體（IOL）市場競爭動態的考察與趨勢

掌握包括醫療保健系統概述真實情況，促進市場了解。市場進入部分還提供有關償付政策和監管環境的訊息，能夠更深入地研究市場動態。

• 各國醫療保健系統概覽
• 依國家/地區劃分的償付政策
• 各國醫療科技監理狀況

目標公司

• Alcon Inc
• Johnson & Johnson Vision Care Inc
• Hoya Corp
• Carl Zeiss Meditec AG
• Bausch and Lomb Inc
• STAAR Surgical Company
• 其他

Intraocular Lens (IOL) Market Size by Segments, Share, Regulatory, Reimbursement, Procedures and Forecast to 2033 is built to visualize quantitative and qualitative market trends within Ophthalmic Devices therapeutic area.

Intraocular Lens is an artificial lens made of plastic, silicone, acrylic or other material that is implanted inside the eye during cataract surgery.

Vision impairment severely impacts quality of life among adult populations. Adults with vision impairment often have lower rates of workforce participation and productivity. In the case of older adults, vision impairment can contribute to social isolation, difficulty walking, a higher risk of falls and fractures, and a greater likelihood of early entry into nursing or care homes. Population growth and ageing are expected to increase the risk that more people acquire vision impairment. Vision restoration and rehabilitation is very effective in improving functioning for people with an irreversible vision impairment that can be caused by eye conditions such as cataracts, diabetic retinopathy, glaucoma, consequences of trauma and age-related macular degeneration.

Each of the covered 39 countries color-coded and fully-sourced market models are equipped with epidemiology based indications with procedure volumes. The interactive excel deliverable covers value, volumes, product usage, average selling prices, market size and company share/rank analysis (wherever available). Moreover, analyst comments with qualitative insight offer context for quantitative data.

Key Inclusions of the market model are -

Currently marketed Intraocular Lens (IOL) and evolving competitive landscape -

• Insightful review of the key industry trends.
• Annualized total Intraocular Lens (IOL) market revenue by segment and market outlooks from 2015-2033.
• Granular data on total procedures, units, average selling prices and market values by segment.

Global, Regional and Country level market specific insights -

• Qualitative market specific information is available with global trends further broken down into regional trends. In addition, GlobalData analysts provide unique country specific insights on the market.
• SWOT analysis for Intraocular Lens (IOL) market.
• Competitive dynamics insights and trends provided for Intraocular Lens (IOL) market.

Drive the understanding of the market by getting the veritable big picture including an overview of the healthcare system. In addition, the Market Access segment allows you to delve deeper into market dynamics with information on reimbursement policies and the regulatory landscape.

• Country specific overview of the healthcare system.
• Country specific reimbursement policies.
• Country specific medtech regulatory landscape.

Robust methodologies and sources enable the model to provide extensive and accurate overview of the market. Demand and supply-side primary sources are integrated within the syndicated models, including Key Opinion Leaders. In addition, real world data sources are leveraged to determine market trends; these include government procedure databases, hospital purchasing databases, and proprietary online databases.

Companies covered: Alcon Inc, Johnson & Johnson Vision Care Inc, Hoya Corp, Carl Zeiss Meditec AG, Bausch and Lomb Inc, STAAR Surgical Company, and Others.

Countries covered: United States, United Kingdom, Germany, France, Italy, Spain, Brazil, China, India, Russia, Japan, Australia, Canada, Mexico, South Korea, Denmark, Ireland, Netherlands, New Zealand, South Africa, Sweden, Switzerland, Austria, Belgium, Finland, Israel, Norway, Poland, Portugal, Taiwan, Czech Republic, Greece, Hungary, Turkey, Egypt, Saudi Arabia, United Arab Emirates, Argentina, and Chile.

Scope

This Market Model gives important, expert insight you won't find in any other source. The model illustrates qualitative and quantitative trends within the specified market. This model is required reading for -

• CMO executives who must have deep understanding of the Intraocular Lens (IOL) marketplace to make strategic planning and investment decisions.
• Sourcing and procurement executives who must understand crucial components of the supply base in order to make decisions about supplier selection and management.
• Private equity investors that need a deeper understanding of the market to identify and value potential investment targets.

Reasons to Buy

The model will enable you to -

• Develop and design your in-licensing and out-licensing strategies through a review of pipeline products, by identifying key companies.
• Develop business strategies by understanding the trends shaping and driving Intraocular Lens (IOL) market.
• Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the Intraocular Lens (IOL) market in the future.
• Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the company share of market leaders.
• Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage.
• Track device sales in the global and country-specific Intraocular Lens (IOL) market from 2015-2033.
• Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships.